Worldwide Study Finder

Not applicableCompletedINTERVENTIONAL

Effects of Intranasal Oxytocin on Fear Processing in Naturalistic Contexts

ClinicalTrials.gov · NCT05892939 · Registry updated: 2025-04-04

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2023-05-23. Completion: 2024-04-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal Oxytocin(24IU) (drug)
intranasal Placebo (drug)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Not reported

Not applicableCompletedINTERVENTIONAL

Effects of Oxytocin on the Functional Architecture of the Brain Before and After Prolonged Naturalistic Fear Induction

ClinicalTrials.gov · NCT05896553 · Registry updated: 2025-04-04

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2023-05-29. Completion: 2024-04-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal Oxytocin(24IU) (drug)
intranasal Placebo (drug)

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Third Stage of Labor a Swedish Randomized Controlled Trial

ClinicalTrials.gov · NCT01221051 · Registry updated: 2025-04-01

Condition / research focus: Childbirth
Sponsor: Göteborg University
Countries with listed sites: No country reported
Registry dates and results: Start: 2006-11. Completion: 2008-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

active management of the third stage of labor (procedure) — also listed as: AMTSL
expectant management of the third stage of labor (procedure) — also listed as: EMTSL

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

The Role of Oxytocin and Interoception in Functional Neurological Disorder

ClinicalTrials.gov · NCT06084325 · Registry updated: 2025-03-27

Condition / research focus: Functional Neurological Disorder
Sponsor: University of Fribourg
Countries with listed sites: Switzerland
Registry dates and results: Start: 2023-10-05. Completion: 2025-01-24 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Respiration resistance sensitivity task (RRST) (device) — also listed as: Respiration resistance device
Heartbeat Tracking (HBT) (behavioral) — also listed as: ECG
Heartbeat evoked potential (HEP) (device) — also listed as: ECG + EEG
Libet task (device) — also listed as: Respiration belt + EEG

Where the study takes place — 2 listed sites

Inselspital
Bern, Canton of Bern, Switzerland
Site recruitment: Not reported
University of Fribourg
Fribourg, Canton of Fribourg, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The Role of Oxytocin-receptor Signalling in Physiological Regulation of Eating Behaviour in Individuals with Obesity

ClinicalTrials.gov · NCT06189001 · Registry updated: 2025-03-27

Condition / research focus: Adiposity
Sponsor: University Hospital, Gentofte, Copenhagen
Countries with listed sites: Denmark
Registry dates and results: Start: 2024-01-01. Completion: 2024-09-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (saline) (other)

Where the study takes place — 1 listed sites

Center for Clinical Metabolisk Research
Hellerup, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

Oxytocin and Brain Responses in Maternal Addiction

ClinicalTrials.gov · NCT02979093 · Registry updated: 2025-03-26

Condition / research focus: Maternal Behavior; Maternal Addiction
Sponsor: Lane Strathearn, MBBS PhD
Countries with listed sites: United States
Registry dates and results: Start: 2017-05-05. Completion: 2021-05-17 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin, Syntocinon
Placebos (drug)
Functional MRI scanning (procedure)

Where the study takes place — 2 listed sites

Yale Child Study Center
New Haven, Connecticut, United States
Site recruitment: Not reported
University of Iowa
Iowa City, Iowa, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Effects of Carbetocin and Oxytocin Used in Cesarean Sections on Postoperative Pain

ClinicalTrials.gov · NCT06692621 · Registry updated: 2025-03-24

Condition / research focus: PREG1
Sponsor: Ankara City Hospital Bilkent
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2024-10-04. Completion: 2025-01-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Deva İlaç Sanayi, Turkey
Carbetocin (drug) — also listed as: Ferring GmbH, Germany

Where the study takes place — 1 listed sites

Ankara Bilkent City Hospital
Ankara, Ankara, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Comparative Study Between Oxytocin Infusion Before and After Placental Delivery on Blood Loss During and After Cesarean Delivery .

ClinicalTrials.gov · NCT06889155 · Registry updated: 2025-03-21

Condition / research focus: Intraoperative Blood Loss
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2023-08-30. Completion: 2024-09-14 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 1 listed sites

Armed force faculty of medicine
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

The Effect of Breastfeeding Counseling on Social Support Perception, Breastfeeding Self-Efficacy and Outcomes

ClinicalTrials.gov · NCT06266806 · Registry updated: 2025-03-20

Condition / research focus: Breastfeeding, Exclusive; Nurse's Role; Self Efficacy
Sponsor: Ondokuz Mayıs University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2024-07-15. Completion: 2025-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Nurse Consultancy Program to Develop Breastfeeding Self-Efficacy Resources (behavioral)

Where the study takes place — 1 listed sites

Kars Harakani State Hospital
Kars, Center, Turkey (Türkiye)
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1 / Phase 2TerminatedINTERVENTIONAL

Dose Response Relationship of Oxytocin on Irritability in Youths

ClinicalTrials.gov · NCT03863288 · Registry updated: 2025-03-14

Condition / research focus: Irritable Mood
Sponsor: University of Nebraska
Countries with listed sites: United States
Registry dates and results: Start: 2022-02-18. Completion: 2024-02-27 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Functional MRI (fMRI) (procedure)
Oxytocin Intranasal Spray 8 International Unit (8IU) (drug)
Oxytocin intranasal spray 24 International Unit (24IU) (drug)
Oxytocin intranasal spray 48 International Unit (48IU) (drug)
Oxytocin intranasal spray 80 International Unit (80IU) (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

University of Nebraska Medical Center, Department of Psychiatry
Omaha, Nebraska, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin and Sleeve Gastrectomy

ClinicalTrials.gov · NCT05307133 · Registry updated: 2025-03-05

Condition / research focus: Obesity, Morbid
Sponsor: Centre Hospitalier Universitaire de Nice
Countries with listed sites: France
Registry dates and results: Start: 2022-11-24. Completion: 2025-03-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Sleeve Gastreextomy (other)

Where the study takes place — 1 listed sites

CHU de Nice
Nice, Alpes-maritimes, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

Does Oxytocin Alter Tolerance to or Motivation for Alcohol

ClinicalTrials.gov · NCT05312008 · Registry updated: 2025-03-04

Condition / research focus: Alcohol Use Disorder
Sponsor: Indiana University
Countries with listed sites: United States
Registry dates and results: Start: 2022-01-16. Completion: 2023-12-21 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin (drug)
Intranasal placebo (drug)

Where the study takes place — 1 listed sites

University Hospital
Indianapolis, Indiana, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin and Approach-avoid in Grief

ClinicalTrials.gov · NCT04505904 · Registry updated: 2025-03-04

Condition / research focus: Prolonged Grief Disorder; Bereavement
Sponsor: University of Arizona
Countries with listed sites: United States
Registry dates and results: Start: 2015-03-20. Completion: 2017-05-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

University of Arizona
Tucson, Arizona, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Evaluation of MDMA on Startle Response

ClinicalTrials.gov · NCT03181763 · Registry updated: 2025-03-04

Condition / research focus: Startle Response
Sponsor: Resilient Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2017-03-14. Completion: 2020-08-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Placebo (drug) — also listed as: inactive placebo, lactose
Midomafetamine (drug) — also listed as: 3,4-methylenedioxymethamphetamine, MDMA, midomafetamine HCl
Acoustic startle (behavioral) — also listed as: startle test

Where the study takes place — 1 listed sites

Emory University
Atlanta, Georgia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

The Role of OXytocin in Acute Ischemic Stroke reconvAlesceNcE: The ROXANE Study

ClinicalTrials.gov · NCT05873309 · Registry updated: 2025-03-04

Condition / research focus: Acute Ischemic Stroke
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2023-04-26. Completion: 2024-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

University Hospital Basel
Basel, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Somatic Psychoeducational Intervention

ClinicalTrials.gov · NCT06580119 · Registry updated: 2025-03-03

Condition / research focus: Work Related Stress
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2024-10-15. Completion: 2025-02-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Somatic Psychoeducational Intervention (behavioral)

Where the study takes place — 1 listed sites

The LJD Jewish Family & Community Services (JFCS) Headquarters
Jacksonville, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

In Vitro Evaluation of Spontaneous and Oxytocin-induced Contractility of Pregnant Human Myometrium During Exposure to Dexmedetomidine

ClinicalTrials.gov · NCT05511415 · Registry updated: 2025-02-26

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2022-11-02. Completion: 2024-11-22 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: pitocin
Dexmedetomidine (drug)

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Preventing Postpartum Depression With Intranasal Oxytocin

ClinicalTrials.gov · NCT02505984 · Registry updated: 2025-02-25

Condition / research focus: Depression, Postpartum; Anxiety
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2016-01. Completion: 2023-05 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug) — also listed as: Salt solution

Where the study takes place — 1 listed sites

Massachusetts General Hosptial
Boston, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine

ClinicalTrials.gov · NCT05679908 · Registry updated: 2025-02-25

Condition / research focus: Chronic Migraine; Chronic Migraine, Headache; Chronic Migraine Without Aura; Aura Migraine
Sponsor: Tonix Pharmaceuticals, Inc.
Countries with listed sites: United States
Registry dates and results: Start: 2022-12-06. Completion: 2023-10-23 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

TNX-1900 (drug) — also listed as: intranasal oxytocin
Placebo Nasal Spray (drug)

Where the study takes place — 26 listed sites

Preferred Research Partners, Inc.
Little Rock, Arkansas, United States
Site recruitment: Not reported
Synergy Research Centers - Synergy San Diego
Lemon Grove, California, United States
Site recruitment: Not reported
Excell Research
Oceanside, California, United States
Site recruitment: Not reported
Viking Clinical Research, LTD
Temecula, California, United States
Site recruitment: Not reported
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, United States
Site recruitment: Not reported
Segal Trials - Miami Lakes Medical Research Outpatient Site
Miami Lakes, Florida, United States
Site recruitment: Not reported
Clinical Neuroscience Solutions, Inc.
Orlando, Florida, United States
Site recruitment: Not reported
Diamond Headache Clinic
Chicago, Illinois, United States
Site recruitment: Not reported
Integrated Clinical Trial Services, Inc.
West Des Moines, Iowa, United States
Site recruitment: Not reported
Alliance for Multispecialty Research - Wichita West
Wichita, Kansas, United States
Site recruitment: Not reported
DelRicht Research - LCMC Health Urgent Care
New Orleans, Louisiana, United States
Site recruitment: Not reported
DelRicht Research - Neighborhood Health
Prairieville, Louisiana, United States
Site recruitment: Not reported
Boston Clinical Trials, Inc.
Boston, Massachusetts, United States
Site recruitment: Not reported
Michigan Headache & Neurological Institute
Ann Arbor, Michigan, United States
Site recruitment: Not reported
DelRicht Research - Gulfport Memorial
Gulfport, Mississippi, United States
Site recruitment: Not reported
Clinvest Research
Springfield, Missouri, United States
Site recruitment: Not reported
Alliance for Multispecialty Research - Las Vegas
Las Vegas, Nevada, United States
Site recruitment: Not reported
Upstate Clinical Research Associates, LLC
Williamsville, New York, United States
Site recruitment: Not reported
Peters Medical Research
High Point, North Carolina, United States
Site recruitment: Not reported
IPS Research Company, INC.
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
DelRicht Research - Grassroots Healthcare
Tulsa, Oklahoma, United States
Site recruitment: Not reported
Coastal Carolina Research Center
North Charleston, South Carolina, United States
Site recruitment: Not reported
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee, United States
Site recruitment: Not reported
Austin Clinical Trial Partners
Austin, Texas, United States
Site recruitment: Not reported
Charlottesville Medical Research, LLC
Charlottesville, Virginia, United States
Site recruitment: Not reported
Clinical Investigation Specialists, Inc.
Kenosha, Wisconsin, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Oxytocin to Enhance Alcohol Behavioral Couple Therapy (ABCT)

ClinicalTrials.gov · NCT03846505 · Registry updated: 2025-02-21

Condition / research focus: Alcohol Use Disorder; Couples
Sponsor: Medical University of South Carolina
Countries with listed sites: United States
Registry dates and results: Start: 2019-05-16. Completion: 2024-01-31 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Placebo (other) — also listed as: Saline

Where the study takes place — 1 listed sites

Medical University of South Carolina
Charleston, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Worldwide Study Finder

Find a study

Registry search results

Effects of Intranasal Oxytocin on Fear Processing in Naturalistic Contexts

Explore the world’s study registries

Worldwide

Africa

Americas

Effects of Oxytocin on the Functional Architecture of the Brain Before and After Prolonged Naturalistic Fear Induction

Third Stage of Labor a Swedish Randomized Controlled Trial

The Role of Oxytocin and Interoception in Functional Neurological Disorder

The Role of Oxytocin-receptor Signalling in Physiological Regulation of Eating Behaviour in Individuals with Obesity

Oxytocin and Brain Responses in Maternal Addiction

Effects of Carbetocin and Oxytocin Used in Cesarean Sections on Postoperative Pain

Comparative Study Between Oxytocin Infusion Before and After Placental Delivery on Blood Loss During and After Cesarean Delivery .

The Effect of Breastfeeding Counseling on Social Support Perception, Breastfeeding Self-Efficacy and Outcomes

Dose Response Relationship of Oxytocin on Irritability in Youths

Oxytocin and Sleeve Gastrectomy

Does Oxytocin Alter Tolerance to or Motivation for Alcohol

Oxytocin and Approach-avoid in Grief

Evaluation of MDMA on Startle Response

The Role of OXytocin in Acute Ischemic Stroke reconvAlesceNcE: The ROXANE Study

Somatic Psychoeducational Intervention

In Vitro Evaluation of Spontaneous and Oxytocin-induced Contractility of Pregnant Human Myometrium During Exposure to Dexmedetomidine

Preventing Postpartum Depression With Intranasal Oxytocin

A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine

Oxytocin to Enhance Alcohol Behavioral Couple Therapy (ABCT)

Asia

Middle East

Europe

Oceania